Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.42 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | SCD | O00767 | 1/20 | 0.38 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16058909 | 1.00 | ALDH1A1 (0.45) | ALDH1A1GPR84HCAR2HPGDHSD17B10 | |
| SCHEMBL3005337 | 1.00 | ALDH1A1 (0.45) | ALDH1A1GPR84HCAR2HPGDHSD17B10 | |
| SCHEMBL27788644 | 1.00 | ALDH1A1 (0.45) | ALDH1A1GPR84HCAR2HPGDHSD17B10 | |
| SCHEMBL3005051 | 1.00 | ALDH1A1 (0.45) | ALDH1A1GPR84HCAR2HPGDHSD17B10 | |
| SCHEMBL2999675 | 0.98 | ALDH1A1 (0.46) | ALDH1A1GPR84HCAR2HPGDHSD17B10 | |
| SCHEMBL3010146 | 0.94 | ALDH1A1 (0.45) | ALDH1A1GPR84HCAR2HPGDHSD17B10 | |
| SCHEMBL3005232 | 0.88 | SCD (0.45) | ALDH1A1GPR84HSD17B10PPARASCD | |
| SCHEMBL2999622 | 0.88 | SCD (0.45) | ALDH1A1GPR84HSD17B10PPARASCD | |
| SCHEMBL3004496 | 0.88 | SCD (0.45) | ALDH1A1GPR84HSD17B10PPARASCD | |
| Acetic Acid SCHEMBL28946334 | 0.88 | KCNH2 (0.47) | ALDH1A1GPR84HCAR2HPGDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100197752-A1 | UROCANIC ACID DERIVATIVES USEFUL FOR THE TREATMENT OF IMMUNE-RELATED AND INFLAMMATORY DISEASES | VALLETTA HEALTH IP EE B.V. (NL) | 2010-08-05 | — | — | US | disclosed |
| EP-2167474-A1 | UROCANIC ACID DERIVATIVES USEFUL FOR THE TREATMENT OF IMMUNE-RELATED AND INFLAMMATORY DISEASES | Valletta Health IP EE B.V. (NL) | 2010-03-31 | — | — | EP | disclosed |
| WO-2008153385-A1 | UROCANIC ACID DERIVATIVES USEFUL FOR THE TREATMENT OF IMMUNE-RELATED AND INFLAMMATORY DISEASES | VALLETTA HEALTH B.V. (NL) | 2008-12-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197752-A1 | UROCANIC ACID DERIVATIVES USEFUL FOR THE TREATMENT OF IMMUNE-RELATED AND INFLAMMATORY DISEASES | UTS2R, UACA, HCAR1 | ALDH1A1 2060/4885GPR84 779/4885HCAR2 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.